Clinical Trials Directory

Trials / Unknown

UnknownNCT00926900

The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Central Institute of Mental Health, Mannheim · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this project is to explore whether the extinction of cue-reactivity following a cue-exposure based intervention in volunteers with an alcohol dependence is facilitated by drugs that increase NMDA-receptor function. It is hypothesised that targeted treatment with D-Cycloserine prior to each extinction training session enhances the effects on cue-reactivity. Further, a significant correlation between the reduction of cue-reactivity and both reduced craving and relapse probability is expected.

Conditions

Interventions

TypeNameDescription
DRUGD-cycloserine50 mg at approximately 1.5 hours prior to cue-exposure training sessions
DRUGPlaceboPlacebo

Timeline

Start date
2009-03-01
Primary completion
2012-04-01
First posted
2009-06-24
Last updated
2011-11-28

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00926900. Inclusion in this directory is not an endorsement.

The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes (NCT00926900) · Clinical Trials Directory